Human low-density lipoprotein receptor gene and its regulation

Journal of Molecular Medicine

Volumn 84, Issue 1, 2006, Pages 29-36

  Kong, Wei Jia ^a,c   Liu, Jingwen ^b   Jiang, Jian Dong ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c Institute of Medicinal Biotechnology   (China)

Author keywords

Hypercholesterolemia; Low density lipoprotein receptor; mRNA stability; Signal transduction pathways; Transcriptional regulatory elements

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; STEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN;

FAMILIAL HYPERCHOLESTEROLEMIA; GENE CONTROL; GENE MUTATION; HUMAN; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

GENE EXPRESSION REGULATION; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MODELS, BIOLOGICAL; RECEPTORS, LDL; RISK FACTORS; TRANSCRIPTION, GENETIC;

EID: 30744466655     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-005-0717-6     Document Type: Review

References (82)

1. Südhoff TC, Goldstein JL, Brown MS, Russell DW (1985) The LDL-receptor gene. A mosaic of exons shared with different proteins. Science 228:815-822
2. Tolleshaug H, Goldstein JL, Schneider WJ, Brown MS (1982) Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia. Cell 30:715-724
3. Yamamoto T, Davis CG, Brown MS, Schneider WJ, Casey ML, Goldstein JL, Russell DW (1984) The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell 39:27-38
4. Defesche JC (2004) Low-density lipoprotein receptor - its structure, function, and mutations. Semin Vasc Med 4:5-11
5. Davis CG, Van Driel IR, Russell DW, Brown MS, Goldstein JL (1987) The LDL-receptor: identification of aminoacids in cytoplasmic domain required for rapid endocytosis. J Biol Chem 262:4075-4079
6. Soutar AK (1996) Intracellular transport of the low-density lipoprotein receptor. Biochem Soc Trans 24:547-552
7. Spady DK (1992) Hepatic clearance of plasma low-density lipoproteins. Semin Liver Dis 12:373-385
8. Brown MS, Goldstein JL (1986) Receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47
9. Hobbs HH, Russell DW, Brown MS, Goldstein JL (1990) The LDL receptor locus in familial hypercholesterolemia: mutation analysis of a membrane protein. Annu Rev Genet 24:133-170
10. Austin MA, Hutter CM, Zimmern RL, Humphries SE (2004) Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol 160:407-420
11. Bays H, Stein EA (2003) Pharmacotherapy for dyslipidaemia - current therapies and future agents. Expert Opin Pharmacother 4:1901-1938
12. Lindgren V, Luskey KL, Russell DW, Francke U (1985) Human genes involved in cholesterol metabolism: chromosomal mapping of the loci for the low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase with cDNA probe. Proc Natl Acad Sci U S A 82:8567-8571
13. Südhoff TC, Van Der Westhuyzen DR, Goldstein JL, Brown MS, Russell DW (1987) Three direct repeats and a TATA-like sequence are required for regulated expression of the human low density lipoprotein receptor gene. J Biol Chem 262:10773-10779
14. Chang R, Yang E, Chamblis D, Kumar A, Wise J, Mehta KD (1996) In vivo role of the Sp1 site neighboring sterol-responsive element-1 in controlling low-density lipoprotein receptor gene expression. Biochem Biophys Res Commun 218:733-739
15. Smith JR, Osborne TF, Goldstein JL, Brown MS (1990) Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene. J Biol Chem 265:2306-2310
16. Wilson GM, Vasa MZ, Deeley RG (1998) Stabilization and cytoskeletal-association of LDL receptor mRNA are mediated by distinct domains in its 3′ untranslated region. J Lipid Res 39:1025-1032
17. Soutar AK, Knight BL (1990) Structure and regulation of the LDL-receptor and its gene. Br Med Bull 46:891-916
18. Catapano AL (1989) The low density lipoprotein receptor: structure, function and pharmacological modulation. Pharmacol Ther 43:187-219
19. Rawson RB (2003) The SREBP pathway - insights from Insigs and insects. Nat Rev Mol Cell Biol 4:631-640
20. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, Goldstein JL, Brown MS (1993) SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 75:187-197
21. Briggs MR, Yokoyama C, Wang X, Brown MS, Goldstein JL (1993) Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. J Biol Chem 268:14490-14496
22. Wang X, Briggs MR, Hua X, Yokoyama C, Goldstein JL, Brown MS (1993) Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization. J Biol Chem 268:14497-14504
23. Horton JD, Goldstein JL, Brown MS (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125-1131
24. Hua X, Sakai J, Ho YK, Goldstein JL, Brown MS (1995) Hairpin orientation of sterol regulatory element-binding protein-2 in cell membranes as determined by protease protection. J Biol Chem 270:29422-29427
25. Wang X, Sato R, Brown MS, Hua X, Goldstein JL (1994) SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 77:53-62
26. Nohturfft A, Brown MS, Goldstein JL (1998) Topology of SREBP cleavage activating protein, a polytopic membrane protein with a sterol sensing domain. J Biol Chem 273:17243-17250
27. Hua X, Nohturfft A, Goldstein JL, Brown MS (1996) Sterol resistance in CHO cells traced to point mutations in SREBP cleavage activating protein (SCAP). Cell 87:415-426
28. Yang T, Espenshade PJ, Wright ME, Yabe D, Gong Y, Aebersold R, Goldstein JL, Brown MS (2002) Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110:489-500
29. Yabe D, Brown MS, Goldstein JL (2002) Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins. Proc Natl Acad Sci U S A 99:12753-12758
30. Radhakrishnan A, Sun LP, Kwon HJ, Brown MS, Goldstein JL (2004) Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain. Mol Clell 15:259-268
31. Brown AJ, Sun L, Feramisco JD, Brown MS, Goldstein JL (2002) Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol Cell 10:237-245
32. Adams CM, Goldstein JL, Brown MS (2003) Cholesterol-induced conformational change in SCAP enhanced by Insig proteins and mimicked by cationic amphiphiles. Proc Natl Acad Sci U S A 100:10647-10652
33. Espenshade PJ, Li WP, Yabe D (2002) Sterols block binding of COPII proteins to SCAP, thereby controlling SCAP sorting in ER. Proc Natl Acad Sci U S A 99:11694-11699
34. Brown MS, Goldstein JL (1999) A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A 96:11041-11048
35. Nohturfft A, DeBose-Boyd RA, Scheek S, Goldstein JL, Brown MS (1999) Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi. Proc Natl Acad Sci U S A 96:11235-11240
36. Duncan EA, Brown MS, Goldstein JL, Sakai J (1997) Cleavage site for sterol-regulated protease located to a Leu-Ser bond in the lumenal loop of sterol regulatory element-binding protein-2. J Biol Chem 272:12778-12785
37. Duncan EA, Dave UP, Sakai J, Goldstein JL, Brown MS (1998). Second-site cleavage in sterol regulatory element-binding protein occurs at transmembrane junction as determined by cysteine panning. J Biol Chem 273:17801-17809
38. Hirano Y, Yoshida M, Shimizu M, Sato R (2001) Direct demonstration of rapid degradation of nuclear sterol regulatory element-binding proteins by the ubiquitin-proteasome pathway. J Biol Chem 276:36431-36437
39. Corsini A, Bellosta S, Baetta R, Fumagalli R, Paoletti R, Bernini F (1999) New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol Ther 84:413-428
40. Auwerx JH, Chait A, Wolfbauer G, Deeb SS (1989) Involvement of second messengers in regulation of the low-density lipoprotein receptor gene. Mol Cell Biol 9:2298-2302
41. Windler EET, Kovanen PT, Chao Y, Brown MS, Havel RJ, Goldstein JL (1980) The estradiol-stimulated lipoprotein receptor of rat liver. J Biol Chem 255:10464-10471
42. Hodgin JB, Maeda N (2002) Minireview: estrogen and mouse models of atherosclerosis. Endocrinology 143:4495-4501
43. Inukai T, Takanashi K, Takebayashi K, Tayama K, Aso Y, Takiguchi Y, Takemura Y (2000) Estrogen markedly increases LDL-receptor activity in hypercholesterolemic patients. J Med 31:247-261
44. Brüning JC, Lingohr P, Gillette J, Haustein B, Avci H, Krone W, Müller-Wieland D, Kotzka J (2003) Estrogen receptor-α and Sp1 interact in the induction of the low density lipoprotein-receptor. J Steroid Biochem Mol Biol 86:113-121
45. Li C, Briggs MR, Ahlborn TE, Kraemer FB, Liu J (2001) Requirement of Sp1 and estrogen receptor α interaction in 17β-estradiol-mediated transcriptional activation of the low density lipoprotein receptor gene expression. Endocrinology 142:1546-1553
46. Parini P, Angelin B, Rudling M (1997) Importance of estrogen receptors in hepatic LDL receptor regulation. Arterioscler Thromb Vasc Biol 17:1800-1805
47. Ness GC (1991) Thyroid hormone. Basis for its hypocholesterolemic effect. J Fla Med Assoc 78:383-385
48. Bakker O, Hudig F, Meijssen S, Wiersinga WM (1998) Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene. Biochem Biophys Res Commun 249:517-521
49. Ness GC, Lopez D (1995) Transcriptional regulation of rat hepatic low-density lipoprotein receptor and cholesterol 7-α-hydroxylase by thyroid hormone. Arch Biochem Biophys 323:404-408
50. Duntas LH (2002) Thyroid disease and lipids. Thyroid 12:287-293
51. Wade DP, Knight BL, Soutar AK (1989) Regulation of low-density- lipoprotein-receptor mRNA by insulin in human hepatoma HepG2 cells. Eur J Biochem 181:727-731
52. Duvillard L, Florentin E, Lizard G, Petit JM, Galland F, Monier S, Gambert P, Verges B (2003) Cell surface expression of LDL receptor is decreased in type 2 diabetic patients and is normalized by insulin therapy. Diabetes Care 26:1540-1544
53. Streicher R, Kotzka J, Müller-Wieland D, Siemeister G, Munck M, Avci H, Krone W (1996) SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-I. J Biol Chem 271:7128-7133
54. Kotzka J, Müller-Wieland D, Roth G, Kremer L, Munck M, Schürmann S, Knebel B, Krone W (2000) Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade. J Lipid Res 41:99-108
55. Kotzka J, Müller-Wieland D, Koponen A, Njamen D, Kremer L, Roth G, Munck M, Knebel B, Krone W (1998) ADD1/SREBP-1c mediates insulin-induced gene expression linked to the MAP kinase pathway. Biochem Biophys Res Commun 249:375-379
56. Roth G, Kotzka J, Kremer L, Lehr S, Lohaus C, Meyer HE, Krone W, Müller-Wieland D (2000) MAP kinases Erk1/2 phosphorylate sterol regulatory element-binding protein (SREBP)-1a at serine 117 in vitro. J Biol Chem 275:33302-33307
57. Kotzka J, Lehr S, Roth G, Avci H, Knebel B, Müller-Wieland D (2004) Insulin-activated Erk-mitogen-activated protein kinases phosphorylate sterol regulatory element-binding protein-2 at serine residues 432 and 455 in vivo. J Biol Chem 279:22404-22411
58. Stopeck AT, Nicholson AC, Mancini FP, Hajjar DP (1993) Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells. J Biol Chem 268:17489-17494
59. Gierens H, Nauck M, Roth M, Schinker R, Schürmann C, Scharnagl H, Neuhaus G, Wieland H, März W (2000) Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements. Arterioscler Thromb Vasc Biol 20:1777-1783
60. Liu J, Streiff R, Zhang YL, Vestal RE, Spence MJ, Briggs MR (1997) Novel mechanism of transcriptional activation of hepatic LDL receptor by oncostatin M. J Lipid Res 38:2035-2048
61. Hardardottir I, Grunfeld C, Feingold KR (1994) Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipidol 5:207-215
62. Zhang F, Lin M, Abidi P, Thiel G, Liu J (2003) Specific interaction of Egrl and c/EBPβ leads to the transcriptional activation of the human low density lipoprotein receptor gene. J Biol Chem 278:44246-44254
63. Liu J, Ahlborn TE, Briggs MR, Kraemer FB (2000) Identification of a novel sterol-independent regulatory element in the human low density lipoprotein receptor promoter. J Biol Chem 275:5214-5221
64. MAPK in interleukin-1β- and tumor necrosis factor-α-induced low density lipoprotein receptor expression in HepG2 cells. J Biol Chem 273:15742-15748
65. Li C, Kraemer FB, Ahlborn TE, Liu J (1999) Induction of low density lipoprotein receptor (LDLR) transcription by oncostatin M is mediated by the extracellular signal-regulated kinase signaling pathway and the repeat 3 element of the LDLR promoter. J Biol Chem 274:6747-6753
66. Basheeruddin K, Li X, Rechtoris C, Mazzone T (1995) Platelet-derived growth factor enhances Sp1 binding to the LDL receptor gene. Arterioscler Thromb Vasc Biol 15:1248-1254
67. Graham A, Russell LJ (1994) Stimulation of low-density lipoprotein uptake in HepG2 cells by epidermal growth factor via a tyrosine kinase-dependent, but protein kinase C-independent mechanism. Biochem J 298:579-584
68. Hsu HY, Nicholson AC, Hajjar DP (1994) Basic fibroblast growth factor-induced low density lipoprotein receptor transcription and surface expression. Signal transduction pathways mediated by the bFGF receptor tyrosine kinase. J Biol Chem 269:9213-9220
69. Mazzone T, Basheeruddin K, Ping L, Frazer S, Getz GS (1989) Mechanism of the growth-related activation of the low density lipoprotein receptor pathway. J Biol Chem 264:1787-1792
70. MAPK cascade alone is sufficient to uncouple LDL receptor expression from cell growth. Mol Cell Biochem 236:13-22
71. Huang W, Mishra V, Batra S, Dillon I, Mehta KD (2004) Phorbol ester promotes histone H3-Ser10 phosphorylation at the LDL receptor promoter in a protein kinase C-dependent manner. J Lipid Res 45:1519-1527
72. Mehta KD (2002) Role of mitogen-activated protein kinases and protein kinase C in regulating low-density lipoprotein receptor expression. Gene Expr 10:153-164
73. Robinson MJ, Cobb MH (1997) Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9:180-186
74. MAPK-induced LDL receptor transcription in HepG2 cells. J Lipid Res 44:584-593
75. MAPK cascade. J Biol Chem 274:19593-19600
76. Wilson GM, Roberts EA, Deeley RG (1997) Modulation of LDL receptor mRNA stability by phorbol esters in human liver cell culture models. J Lipid Res 38:437-446
77. Zubiaga AM, Belasco JG, Greenberg ME (1995) The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol 15:2219-2230
78. Knouff C, Malloy S, Wilder J, Altenburg MK, Maeda N (2001) Doubling expression of the low density lipoprotein receptor by truncation of the 3′-untranslated region sequence ameliorates type III hyperlipoproteinemia in mice expressing the human ApoE2 isoform. J Biol Chem 276:3856-3862
79. Nakahara M, Fujii H, Maloney PR, Shimizu M, Sato R (2002) Bile acids enhance low density lipoprotein receptor gene expression via a MAPK cascade-mediated stabilization of mRNA. J Biol Chem 277:37229-37234
80. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Wang Y, Li Z, Liu J, Jiang JD (2004) Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10:1344-1351
81. Goto D, Okimoto T, Ono M, Shimotsu H, Abe K, Tsujita Y, Kuwano M (1997) Upregulation of low density lipoprotein receptor by gemfibrozil, a hypolipidemic agent, in human hepatoma cells through stabilization of mRNA transcripts. Arterioscler Thromb Vasc Biol 17:2707-2712
82. Kong W, Abidi P, Kraemer FB, Jiang JD, Liu J (2005) In vivo activities of cytokine oncostatin M in regulation of plasma lipid levels. J Lipid Res 46:1163-1171